Skip to content

Albustix® Reagent Strips 10333485Recalls & reported problems

Siemens Healthcare Diagnostics Inc. · ALBUSTIX® are intended for in vitro diagnostic use by healthcare professionals to detect the presence of protein in urine. · Class 2

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00630414550602), received between Mar 1, 2021 and Mar 1, 2021 — classified as 1 malfunction.

The most frequently reported specific device problem is “Non Reproducible Results” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Non Reproducible Results1

Patient problems

  • Insufficient Information1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionMar 1, 2021Non Reproducible Results; Non Reproducible Results

    A PHARMACIST REPORTED THAT A PATIENT TESTED THEIR MORNING URINE SAMPLE WITH TWO DIFFERENT LOTS OF ALBUSTIX FOR PROTEIN AND THE RESULTS WERE NEGATIVE. LATER THAT AFTERNOON, THE PATIENT HAD A NEW URINE SAMPLE RUN IN THE LABORATORY AND THE PROTEIN RESULT WAS 2+. THERE WAS NO REPORT OF INJURY DUE TO THIS EVENT.

    Patient problems: Insufficient Information

    MAUDE report 11396276 ↗

Other METHOD, ENZYMATIC, GLUCOSE (URINARY, NON-QUANTITATIVE) devices

All METHOD, ENZYMATIC, GLUCOSE (URINARY, NON-QUANTITATIVE) devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page